IDEXX Laboratories, Inc.
IDXX
$652.27
$0.160.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.55% | 3.56% | 5.84% | 6.56% | 6.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.55% | 3.56% | 5.84% | 6.56% | 6.35% |
| Cost of Revenue | 7.88% | 1.08% | 2.18% | 3.25% | 3.68% |
| Gross Profit | 12.21% | 5.11% | 8.46% | 8.77% | 8.08% |
| SG&A Expenses | 8.97% | 2.61% | 9.69% | -21.39% | 3.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.57% | 2.52% | 5.53% | -4.70% | 4.76% |
| Operating Income | 14.68% | 5.88% | 6.68% | 32.73% | 9.85% |
| Income Before Tax | 39.87% | 4.94% | 6.98% | 11.58% | -9.40% |
| Income Tax Expenses | 22.61% | 12.53% | -10.87% | 18.70% | -9.62% |
| Earnings from Continuing Operations | 44.61% | 3.01% | 11.12% | 9.71% | -9.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.61% | 3.01% | 11.12% | 9.71% | -9.34% |
| EBIT | 14.68% | 5.88% | 6.68% | 32.73% | 9.85% |
| EBITDA | 14.36% | 6.61% | 7.40% | 31.31% | 10.34% |
| EPS Basic | 48.60% | 5.27% | 12.81% | 10.77% | -8.84% |
| Normalized Basic EPS | 16.16% | 7.24% | 8.60% | 35.83% | 12.72% |
| EPS Diluted | 48.77% | 5.34% | 13.41% | 10.67% | -8.61% |
| Normalized Diluted EPS | 16.39% | 7.55% | 8.78% | 36.05% | 12.90% |
| Average Basic Shares Outstanding | -2.68% | -2.14% | -1.49% | -0.95% | -0.55% |
| Average Diluted Shares Outstanding | -2.88% | -2.42% | -1.66% | -1.12% | -0.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |